...
机译:FDA促进血管紧张素II的分配休克(Vol 19,PG 11,2019)
US FDA Div Cardiovasc &
Renal Prod Ctr Drug Evaluat &
Res 10903 New Hampshire Ave Bldg 22 Room;
US FDA Div Cardiovasc &
Renal Prod Ctr Drug Evaluat &
Res 10903 New Hampshire Ave Bldg 22 Room;
US FDA Div Cardiovasc &
Renal Prod Ctr Drug Evaluat &
Res 10903 New Hampshire Ave Bldg 22 Room;
US FDA Off Clin Pharmacol Ctr Drug Evaluat &
Res Silver Spring MD USA;
US FDA Off Clin Pharmacol Ctr Drug Evaluat &
Res Silver Spring MD USA;
US FDA Off Biostat Ctr Drug Evaluat &
Res Silver Spring MD USA;
US FDA Div Cardiovasc &
Renal Prod Ctr Drug Evaluat &
Res 10903 New Hampshire Ave Bldg 22 Room;
US FDA Off Pharmaceut Qual Ctr Drug Evaluat &
Res Silver Spring MD USA;
US FDA Div Cardiovasc &
Renal Prod Ctr Drug Evaluat &
Res 10903 New Hampshire Ave Bldg 22 Room;
US FDA Div Cardiovasc &
Renal Prod Ctr Drug Evaluat &
Res 10903 New Hampshire Ave Bldg 22 Room;
机译:FDA促进血管紧张素II的分配休克(Vol 19,PG 11,2019)
机译:FDA对血管紧张素II的批准用于治疗分配休克的成人体内的低血压
机译:血管紧张素II可能用于治疗分布性休克性低血压,但安全有效的剂量尚不清楚
机译:isiimash pgu-11设施中的美国/俄罗斯高超音速燃烧研究实验
机译:热休克蛋白防止血管紧张素II诱导的心血管炎症
机译:血管紧张素II可能用于治疗分布性休克性低血压但安全有效的剂量尚不清楚
机译:FDA对血管紧张素II的批准用于分配休克分配休克治疗体内的低血压